More People Who Inject Drugs Are Being Treated for Hepatitis C

More People Who Inject Drugs Are Being Treated for Hepatitis C

From 2015 to 2018, the proportion of people who inject drugs who have received treatment for hepatitis C has almost tripled in San Francisco, according to results published in PLOS ONE. Because 80% of hepatitis C transmissions occur among people who inject drugs, this group faces a greater risk of contracting the virus and—if left untreated—developing complications, such as cirrhosis and liver cancer. Two thirds of the approximately 22,000 individuals who tested positive for antibodies to hepatitis C virus (HCV) in San Francisco in 2016 were people who inject drugs. In order to better implement efforts to eliminate hepatitis C by 2030—a goal set by the United States and the World Health Organization—data on whether people who inject drugs are plugged into care is needed. More than 1,400 people who inject drugs would need to be treated annually in order to eliminate hepatitis C by 2030 in San Francisco, the researchers estimated.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!